Google
ENOV 株価分析 — ENOVIS CORP (Healthcare >> Medical Devices)
ENOV に関するよくある質問
ENOVのPER（株価収益率）は？
ENOVIS CORP（ENOV）は現在PER -200.52倍で取引されています。
ENOVのROE（自己資本利益率）は？
ENOVIS CORPのROEは-77.00%です。
ENOVの配当利回りは？
ENOVIS CORPの配当利回りは0.00%です。
ENOVの品質スコア（Quality Score）は？
当社のAIはENOVの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ENOVは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ENOVはどのセクターに属しますか？
ENOVIS CORPはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）
ENOV AI Analysis Summary
Our AI summary for ENOV: ENOVIS CORP (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of -200.52, ROE of -77.00%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 29.15
Price
-0.15
(-0.51%)
Day Change
|
|
|---|
ENOV, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 29.15 |
| PBV / Sector |
1.14 / -101.57
GREAT
|
| Earning Per Share | -19.66 |
| PE / Sector |
N/A / 31.23
|
| PEG or PE/Growth / Sector |
-0.24 / 0.40
|
| Average 1M Daily Value |
24.89 M
GREAT
|
| Average 1W Daily Value |
23.62 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
62% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:47 |
| Symbol | ENOV |
| Name | ENOVIS CORP |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 57.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,686.58 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2711 Centerville Road, Wilmington, DE, United States, 19808
Phone: 302 252 9160
Website: https://www.enovis.com
Employees: 7,802
Sector: Healthcare >> Medical Devices
Description: Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
